Colgate-Palmolive (NYSE:CL) Shares Bought by Bath Savings Trust Co

Bath Savings Trust Co lifted its holdings in shares of Colgate-Palmolive (NYSE:CL) by 2.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 58,137 shares of the company’s stock after buying an additional 1,655 shares during the period. Bath Savings Trust Co’s holdings in Colgate-Palmolive were worth $5,285,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Diversified Trust Co lifted its position in Colgate-Palmolive by 2.6% during the 4th quarter. Diversified Trust Co now owns 83,360 shares of the company’s stock worth $7,578,000 after acquiring an additional 2,125 shares during the period. Canandaigua National Bank & Trust Co. raised its stake in shares of Colgate-Palmolive by 3.4% during the fourth quarter. Canandaigua National Bank & Trust Co. now owns 12,534 shares of the company’s stock worth $1,139,000 after purchasing an additional 412 shares during the last quarter. CWA Asset Management Group LLC lifted its holdings in shares of Colgate-Palmolive by 27.4% during the fourth quarter. CWA Asset Management Group LLC now owns 32,842 shares of the company’s stock worth $2,986,000 after purchasing an additional 7,056 shares during the period. Pensionfund Sabic grew its position in Colgate-Palmolive by 43.8% in the 4th quarter. Pensionfund Sabic now owns 19,700 shares of the company’s stock valued at $1,791,000 after buying an additional 6,000 shares during the last quarter. Finally, Nordea Investment Management AB increased its stake in Colgate-Palmolive by 32.5% in the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock valued at $462,121,000 after buying an additional 1,247,731 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Trading Up 0.2 %

Shares of CL traded up $0.21 during mid-day trading on Tuesday, hitting $87.75. The company had a trading volume of 1,893,685 shares, compared to its average volume of 3,555,586. Colgate-Palmolive has a 1-year low of $79.69 and a 1-year high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The business’s 50-day simple moving average is $93.18 and its 200-day simple moving average is $98.38. The stock has a market cap of $71.69 billion, a PE ratio of 25.14, a P/E/G ratio of 3.31 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.28%. Colgate-Palmolive’s payout ratio is 57.31%.

Analyst Ratings Changes

Several analysts have recently commented on the stock. TD Cowen reduced their target price on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and raised their price objective for the company from $107.00 to $109.00 in a research report on Monday, September 9th. Piper Sandler dropped their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday. Wells Fargo & Company reduced their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday. Finally, JPMorgan Chase & Co. upped their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average target price of $104.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.